文献速递冠心病血脂与心血管预防

纽蛋白磷酸化破坏血管内皮连接促进动脉粥样硬化

Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis.
PubMed 文献 · Eur Heart J · 2023-01-01

研究利用猪模型、大规模磷酸化蛋白质组学、转基因小鼠和临床标本,发现扰动流诱导内皮细胞纽蛋白(VCL)丝氨酸721位点磷酸化(VCLS721p),该过程由GRK2S29p介导,导致VE-钙黏蛋白/连环蛋白复合物破坏,增加内皮通透性和动脉粥样硬化。内皮VCLS721p是动脉粥样硬化进展的关键临床病理生物标志物,血清VCLS721p水平是CAD诊断的有前景生物标志物,GRK2抑制剂可抑制斑块形成。

要点

  • 扰动流通过GRK2S29p诱导内皮VCLS721p,破坏内皮连接并促进动脉粥样硬化。
  • 内皮VCLS721p是动脉粥样硬化进展的关键临床病理生物标志物。
  • 血清VCLS721p水平是CAD诊断的有前景生物标志物,GRK2抑制剂可抑制斑块形成。

核心结论

  • 内皮VCLS721p是动脉粥样硬化相关血管疾病临床评估和治疗的有价值血流动力学靶点。

研究设计与样本

  • 研究采用猪模型、大规模磷酸化蛋白质组学、转基因小鼠和临床标本。
  • 在猪主动脉扰动流(易感动脉粥样硬化)与搏动流(抗动脉粥样硬化)区域的内皮中进行大规模磷酸化蛋白质组学分析。
  • 构建在内皮细胞过表达S721非磷酸化VCL突变体的ApoE-/-小鼠。
  • 对ApoE-/-小鼠给予GRK2抑制剂。
  • 研究冠状动脉疾病(CAD)患者的临床标本。

主要发现

  • 扰动流诱导内皮细胞VCL丝氨酸721位点磷酸化(VCLS721p)。
  • VCLS721p的诱导由GRK2S29p介导,导致VCL闭合构象失活,破坏VE-钙黏蛋白/连环蛋白复合物,增加内皮通透性和动脉粥样硬化。
  • 内皮过表达S721非磷酸化VCL突变体的ApoE-/-小鼠证实VCLS721p在促进动脉粥样硬化中的关键作用。
  • 给予GRK2抑制剂抑制ApoE-/-小鼠内皮VCLS721p,从而抑制斑块形成。
  • CAD患者临床标本显示内皮VCLS721p是动脉粥样硬化进展的关键临床病理生物标志物,血清VCLS721p水平是CAD诊断的有前景生物标志物。

临床怎么用

  • 内皮VCLS721p可作为动脉粥样硬化相关血管疾病临床评估的血流动力学靶点。
  • 血清VCLS721p水平有望作为CAD诊断的生物标志物。
  • GRK2抑制剂可能通过抑制内皮VCLS721p抑制斑块形成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Atherosclerosis preferentially develops in arterial branches and curvatures where vascular endothelium is exposed to disturbed flow. In this study, the effects of disturbed flow on the regulation of vascular endothelial phosphoproteins and their contribution to therapeutic application in atherogenesis were elucidated. METHODS: Porcine models, large-scale phosphoproteomics, transgenic mice, and clinical specimens were used to discover novel site-specific phosphorylation alterations induced by disturbed flow in endothelial cells (ECs). RESULTS: A large-scale phosphoproteomics analysis of native endothelium from disturbed (athero-susceptible) vs. pulsatile flow (athero-resistant) regions of porcine aortas led to the identification of a novel atherosclerosis-related phosphoprotein vinculin (VCL) with disturbed flow-induced phosphorylation at serine 721 (VCLS721p). The induction of VCLS721p was mediated by G-protein-coupled receptor kinase 2 (GRK2)S29p and resulted in an inactive form of VCL with a closed conformation, leading to the VE-cadherin/catenin complex disruption to enhance endothelial permeability and atherogenesis. The generation of novel apolipoprotein E-deficient (ApoE-/-) mice overexpressing S721-non-phosphorylatable VCL mutant in ECs confirmed the critical role of VCLS721p in promoting atherosclerosis. The administration of a GRK2 inhibitor to ApoE-/- mice suppressed plaque formation by inhibiting endothelial VCLS721p. Studies on clinical specimens from patients with coronary artery disease (CAD) revealed that endothelial VCLS721p is a critical clinicopathological biomarker for atherosclerosis progression and that serum VCLS721p level is a promising biomarker for CAD diagnosis. CONCLUSIONS: The findings of this study indicate that endothelial VCLS721p is a valuable hemodynamic-based target for clinical assessment and treatment of vascular disorders resulting from atherosclerosis.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Shih YT, Wei SY, Chen JH, et al. Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis. Eur Heart J. 2023. PMID: 36380599. doi:10.1093/eurheartj/ehac647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。